FibroGen (FGEN) Misses Q2 EPS by $1.79

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($1.88), $1.79 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.35 million versus the consensus estimate of $2.88 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Nauticus Robotics (KITT) Reports Q2 Loss of $2.30
• Nvidia and Broadcom AI financing deals raise long-term concerns, Wolfe Research comments
• Deutsche Bank Downgrades Qifu Technology (3660:HK) (QFIN) to Hold